PolarCool attend the UEFA Medical Symposium in Frankfurt as an Official Gold Partner

Report this content

The Med-tech company PolarCool announces that they will attend the event as an official Gold Partner, as one of only 14 other external partners selected to participate. The +250 VIP circle, of soccer’s leading medical doctors, opens up to external partners for the 1st time.

PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussion. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, as well as other sports with an increased risk of concussion.

The theme of the 8th UEFA Medical Symposium organized by UEFA and the German Football Association (DFB) is 'The importance of medicine in football', focusing on the significant evolution of football medicine in the last few years. National team doctors of all UEFA member associations as well as medical doctors of the top European clubs will participate in the event.

The company has recently communicated its sales goals for 2023, which is estimated to increase to 100-150 rented systems on the market by the end of 2023. The participation in the UEFA Medical Symposium is an important step in creating further exposure and interest in the PolarCap System.

PolarCool CEO Erik Andersson comments;

-The UEFA Medical Symposium serves as a fantastic opportunity to showcase PolarCap in front of the leading medical personnel in European soccer. The fact that PolarCool has gone through a selection process with the UEFA Medical Committee and has been selected to participate as a partner is very encouraging.

 For more information

Erik Andersson –  CEO PolarCool AB (publ)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se
 

About PolarCool AB (publ)

PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.